Login / Signup

Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma.

Aliza GardenswartzBrinda MehtaNader Kim El-MallawanyCarmella Van de VenJessica HochbergAllyson FlowerErin MorrisLauren HarrisonYaya ChuJaclyn BassoPerry GerardHumayun IslamJanet AyelloLee Ann Baxter-LoweMitchell S Cairo
Published in: Leukemia & lymphoma (2022)
Keyphrases